(PDF) Comparison of the in Vitro Activity of the

Comparison of the in Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) With Those of Tetracycline, Minocycline, and Doxycycline Against Isolates of Nontuberculous Mycobacteria

Antimicrobial Agents and Chemotherapy - United States

doi 10.1128/aac.46.10.3164-3167.2002

Full Text

Open PDF

Abstract

Available in full text

Date

October 1, 2002

Authors

Richard J. Wallace

Barbara A. Brown-Elliott

Christopher J. Crist

Linda Mann

Rebecca W. Wilson

Publisher

American Society for Microbiology

Related search

Antipneumococcal Activities of GAR-936 (A New Glycylcycline) Compared to Those of Nine Other Agents Against Penicillin-Susceptible and -Resistant Pneumococci

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2000

English

In Vitro and in Vivo Activities of Tigecycline (GAR-936), Daptomycin, and Comparative Antimicrobial Agents Against Glycopeptide-Intermediate Staphylococcus Aureus and Other Resistant Gram-Positive Pathogens

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2002

English

Comparative in Vitro Antimicrobial Activity of Tigecycline, a New Glycylcycline Compound, in Freshly Prepared Medium and Quality Control

Journal of Clinical Microbiology

Microbiology

2007

English

In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline Against Drug-Resistant Clinical Isolates of Mycobacterium Abscessus

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

The Many Lives of Nontuberculous Mycobacteria

Journal of Bacteriology

Microbiology

Molecular Biology

2018

English

In Vitro Activities of Benflumetol Against 158 Senegalese Isolates of Plasmodium Falciparum in Comparison With Those of Standard Antimalarial Drugs

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1999

English

Antimicrobial Susceptibility Among Pathogens Collected From Hospitalized Patients in the United States and in Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2006

English

Tigecycline Potentiates Clarithromycin Activity Against Mycobacterium Avium in Vitro

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2016

English

In Vitro Activity of Apalcillin Compared With Those of Piperacillin and Carbenicillin Against 6,797 Bacterial Isolates From Four Separate Medical Centers.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1984

English

Amanote Research

Comparison of the in Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) With Those of Tetracycline, Minocycline, and Doxycycline Against Isolates of Nontuberculous Mycobacteria

Antimicrobial Agents and Chemotherapy - United States

doi 10.1128/aac.46.10.3164-3167.2002

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Antipneumococcal Activities of GAR-936 (A New Glycylcycline) Compared to Those of Nine Other Agents Against Penicillin-Susceptible and -Resistant Pneumococci

In Vitro and in Vivo Activities of Tigecycline (GAR-936), Daptomycin, and Comparative Antimicrobial Agents Against Glycopeptide-Intermediate Staphylococcus Aureus and Other Resistant Gram-Positive Pathogens

Comparative in Vitro Antimicrobial Activity of Tigecycline, a New Glycylcycline Compound, in Freshly Prepared Medium and Quality Control

In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline Against Drug-Resistant Clinical Isolates of Mycobacterium Abscessus

The Many Lives of Nontuberculous Mycobacteria

In Vitro Activities of Benflumetol Against 158 Senegalese Isolates of Plasmodium Falciparum in Comparison With Those of Standard Antimalarial Drugs

Antimicrobial Susceptibility Among Pathogens Collected From Hospitalized Patients in the United States and in Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial

Tigecycline Potentiates Clarithromycin Activity Against Mycobacterium Avium in Vitro

In Vitro Activity of Apalcillin Compared With Those of Piperacillin and Carbenicillin Against 6,797 Bacterial Isolates From Four Separate Medical Centers.